Silence Therapeutics
About:
Silence Therapeutics is a drug development company with a proprietary genetic medicine platform.
Website: http://www.silence-therapeutics.com
Twitter/X: silencetheraplc
Top Investors: TCG Crossover, Frazier Life Sciences, Great Point Partners, Redmile Group, Vivo Capital
Description:
Silence Therapeutics plc is a United Kingdom-based ribonucleic acid (RNA) technology company. The Company is primarily involved in the research and development of pharmaceutical products. The Company's technology harnesses the body's natural mechanisms to create therapeutic effects within its own cells. The Company has a has a genetic toolkit with its own therapeutic payloads to modulate gene expression up as well as down in preclinical in vivo models, and delivery systems for various organs and cell types.
$249M
$10M to $50M
London, England, United Kingdom
1999-01-01
info(AT)silence-therapeutics.com
101-250
2024-02-02
Public
© 2025 bioDAO.ai